Could Hormones Make a Difference in the Treatment of Juvenile Rheumatoid Arthritis?

ISSN： 1173-8804

Source： BioDrugs, Vol.13, Iss.2, 2000-02, pp. : 77-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessment of Wrist Malalignment in Juvenile Rheumatoid Arthritis

By Nieuwenhuis Marianne K. van der Net Janjaap Kuis Wietse Buchanan Thomas S. Helders Paul J. M.

Advances in Physiotherapy, Vol. 1, Iss. 2, 1999-12 ,pp. : 99-109

Informa Healthcare

Access to resources Recommend Favorite

Biological Agents in Rheumatoid Arthritis: Which Ones Could Be Used in Combination?

By Lorenz M. Kalden J.R.

BioDrugs, Vol. 9, Iss. 4, 1998-04 ,pp. : 303-324

Adis International

Access to resources Recommend Favorite

Targeting Tumour Necrosis Factor in the Treatment of Rheumatoid Arthritis

By Pearce G.J. Chikanza I.C.

BioDrugs, Vol. 15, Iss. 3, 2001-03 ,pp. : 139-149

Adis International

Access to resources Recommend Favorite

Golimumab: In the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis

By Oldfield Vicki Plosker Greg L.

BioDrugs, Vol. 23, Iss. 2, 2009-06 ,pp. : 125-135

Adis International

Access to resources Recommend Favorite

Spotlight on Etanercept in Rheumatoid Arthritis, Psoriatic Arthritis and Juvenile Rheumatoid Arthritis This Spotlight is derived from abstract and summary text of an Adis Drug Evaluation originally published in full in Drugs 2002; 62 (17): 2493-2537.

By Culy C.R. Keating G.M.

BioDrugs, Vol. 17, Iss. 2, 2003-01 ,pp. : 139-145

Adis International

Access to resources Recommend Favorite